Monograph
A07EA06 - Budesonide |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate for CYPs 3A4. Inhibitor of CYP 2C3.Inducer of CYP 3A5. Several references consider it safe.
Chemical description
Glucocorticoid for local treatment of Mb Crohn. Biovailability 3-50%. Metabolized by CYPs 3A4. South African list: use. French list: authorized. Merck Index: safe Kahlman, Bonkowky: believed to be safe.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Budenofalk · Budesonide · Cortiment · Entocort · Jorveza · Kinpeygo 
Budenofalk · Budesonide · Entocort · Jorveza · Kinpeygo 
Cortiment · Entocord · Intestifalk · Jorveza · Kinpeygo 
Budesonide · Cortiment · Entocir · Intesticort · Jorveza 
Budenofalk · Cortiment · Kinpeygo 
Budenofalk · Budesonide · Cortiment · Entocort · Entocort CR · Jorveza · Kinpeygo 
Budenocare · Budenofalk · Budenopar · Budesonid · Cortiment · Entocort · Jorveza · Kinpeygo 
Budenofalk · Budesonid · Cortiment · Entocort · Jorveza 
Budenofalk · Cortiment MMX · Entocort · Jorveza · Kinpeygo · Xirobud 
Budenofalk · Budesonid · Entocort · Jorveza · Kinpeygo 
Cortiment · Entocort · Jorveza · Kinpeygo 
Budenofalk · Budesonid · Cortiment · Entocort · Jorveza · Kinpeygo 
Budenofalk · Budesonide · Jorveza · Kinpeygo 
Budenofalk · Budosan · Cortiment · Jorveza
© NAPOS 2025